DP
Congress trade
Sen. David Perdue (R-GA) bought $1K-$15K of Pfizer Inc. (PFE) stock
David Perdue, U.S. Senator (R-GA), disclosed a purchase of Pfizer Inc. (PFE) stock worth $1K-$15K in a STOCK Act filing on Mar 3, 2020.
The trade happened on Feb 27, 2020, 5 days before it was made public.
PFE has moved -14.1% since the trade date, from $32.35 to $27.80 (Oct 2, 2026 close).
- Traded
- Feb 27, 2020
- Disclosed
- Mar 3, 2020
- Filing delay
- 5 days
- Price since
- -14.1%
- Source
- STOCK Act disclosure
Other trades in this disclosure (60)
- BuyDAL$15K-$50KMar 3, 2020
- BuyDIS$15K-$50KMar 3, 2020
- BuyPFE$15K-$50KMar 3, 2020
- BuyPFE$15K-$50KMar 3, 2020
- BuyPFE$15K-$50KMar 3, 2020
- BuyPFE$15K-$50KMar 3, 2020
- SellT$15K-$50KMar 3, 2020
- SellT$15K-$50KMar 3, 2020
- SellT$15K-$50KMar 3, 2020
- SellAAPL$1K-$15KMar 3, 2020
- SellALB$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
- SellCZR$1K-$15KMar 3, 2020
More PFE insider and Congress trades
From a public STOCK Act disclosure, linked above. Not investment advice, and not a recommendation to buy or sell.